Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yosef Gilad
Institution:
Baylor College of Medicine
Observed institution:
Baylor College of Medicine
ORCID:
0009-0006-8475-9197
Observed ORCID:
0009-0006-8475-9197
OpenAlex ID:
A5063041861
Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion
2023
·
Sang Jun Han
, Prashi Jain
, et al.
·
Proceedings of the National Academy of Sciences
·
31
Steroid receptor coactivator 3-deficient regulatory T cells eradicate multiple solid tumors in syngeneic mouse models
2026
·
Nuri Sung
, Eunsu Kim
, et al.
·
OncoImmunology
·
2
PDF
Steroid receptor coactivators: from basic research to translational opportunities
2026
·
Yosef Gilad
, Sang Jun Han
, et al.
·
Endocrine Reviews
·
2
Steroid receptor coactivators in immunity - From function to emerging translational opportunities
2026
·
Yosef Gilad
, David M. Lonard
·
Journal of Biological Chemistry
PDF
Abstract 167: Preclinic study of src3-ko regulatory T cells in mouse breast cancer model.
2026
·
Yan Xia
, Yosef Gilad
, et al.
·
Cancer Research
Method for generation and ex vivo expansion of genetically edited mouse Tregs
2025
·
Yosef Gilad
, Adam M Dean
, et al.
·
Journal of Leukocyte Biology
404 Adoptive cell transfer of CRIPSR generated SRC-3 knockout regulatory T cells produce strong anti-tumor activity
2024
·
Yan Xia
, Yosef Gilad
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
7
Citation count:
35
H-index:
2
I10-index:
1
Year
Topic
Type